Am. J. Respir. Cell Mol. Biol., Volume 25, Number 3, September, 2001 272-277

Human Leukocyte Antigen-DRB1 Position 11 Residues Are a Common Protective Marker for Sarcoidosis

Patrick J. Foley, Deirdre S. McGrath, Elzbieta Puscinska, Martin Petrek, Vitezslav Kolek, Jiri Drabek, Penelope A. Lympany, Panagiotis Pantelidis, Kenneth I. Welsh, Jan Zielinski, and Roland M. du Bois

Interstitial Lung Disease Unit, Department of Occupational and Environmental Medicine, National Heart and Lung Institute, Imperial College of Science, Technology, and Medicine, London; Oxford Tissue Typing Centre, Nuffield Department of Surgery, The Churchill Hospital, Oxford, United Kingdom; Institute of Tubercle and Lung Diseases, Warsaw, Poland; Department of Immunology, Medical Faculty of Palacky University; and Department of Respiratory Medicine, University Hospital, Olomouc, Czech Republic

Genetic factors, in particular human leukocyte antigens (HLAs) are important determinants of susceptibility to sarcoidosis, a chronic granulomatous disease of undetermined etiology. To clarify the role of HLA in sarcoidosis we determined HLA-DR and -DQ alleles in case-control samples from three European populations (United Kingdom, Czech, and Polish) and compared these results with those published for three additional populations (Italian, Japanese, and Scandinavian) to determine whether the HLA-DR and/or -DQ alleles act as ethnic-dependent, or ethnic-independent modifiers of disease risk. Although variations were apparent in the alleles associated with susceptibility, reductions in the frequency of alleles associated with protection were remarkably consistent in the six populations. Previously detected associations between single-nucleotide polymorphisms at the TAP2 locus and sarcoidosis were shown to be due to linkage disequilibrium with the HLA-DR locus. The protective HLA-DR alleles, which encode the DR1 and DR4 antigens, were found to share characteristic small hydrophobic residues at position 11, which were replaced by small hydrophilic residues in the remaining, nonprotective, HLA-DR alleles. This residue position is within a pocket of the HLA-DR complex antigen binding groove (designated P6), where it is the only variable amino acid and therefore determines the peptide binding preferences of this pocket. A highly significant reduction in the frequency of individuals carrying HLA-DR alleles with a hydrophobic residue at position 11 was observed in the sarcoidosis cases in the three populations we examined. This suggests this HLA-DR residue is an important protective marker in sarcoidosis.

This article has been cited by other articles:

				I. Campo, P. Morbini, M. Zorzetto, C. Tinelli, E. Brunetta, C. Villa, C. Bombieri, M. Cuccia, C. Agostini, V. Bozzi, et al. Expression of Receptor for Advanced Glycation End Products in Sarcoid Granulomas Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 498 - 506. [Abstract] [Full Text] [PDF]

				R. Valentonyte, J. Hampe, P. J. P. Croucher, J. Muller-Quernheim, E. Schwinger, S. Schreiber, and M. Schurmann Study of C-C Chemokine Receptor 2 Alleles in Sarcoidosis, with Emphasis on Family-based Analysis Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1136 - 1141. [Abstract] [Full Text] [PDF]

				W. J. Martin II, M. C. Iannuzzi, D. B. Gail, and H. H. Peavy Future Directions in Sarcoidosis Research: Summary of an NHLBI Working Group Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 567 - 571. [Abstract] [Full Text] [PDF]

				R. M. Rutherford and J. J. Gilmartin Mycobacteria in Pathogenesis of Sarcoidosis Chest, January 1, 2004; 125(1): 354 - 354. [Full Text] [PDF]

				N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al. Idiopathic Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): S1 - 105. [Full Text] [PDF]

				S. K. Sharma, A. Balamurugan, R. M. Pandey, P. K. Saha, and N. K. Mehra Human Leukocyte Antigen-DR Alleles Influence the Clinical Course of Pulmonary Sarcoidosis in Asian Indians Am. J. Respir. Cell Mol. Biol., August 1, 2003; 29(2): 225 - 231. [Abstract] [Full Text] [PDF]

				M. C. Iannuzzi, M. J. Maliarik, L. M. Poisson, and B. A. Rybicki Sarcoidosis Susceptibility and Resistance HLA-DQB1 Alleles in African Americans Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1225 - 1231. [Abstract] [Full Text] [PDF]

				B. A. Rybicki, M. J. Maliarik, L. M. Poisson, R. Sheffer, K. M. Chen, M. Major, G. A. Chase, and M. C. Iannuzzi The Major Histocompatibility Complex Gene Region and Sarcoidosis Susceptibility in African Americans Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 444 - 449. [Abstract] [Full Text] [PDF]

				D. R. Moller and E. S. Chen Genetic Basis of Remitting Sarcoidosis: Triumph of the Trimolecular Complex? Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 391 - 395. [Full Text] [PDF]

				H. Sato, J. C. Grutters, P. Pantelidis, A. N. Mizzon, T. Ahmad, A.-J. van Houte, J.-W. J. Lammers, J. M.M. van den Bosch, K. I. Welsh, and R. M. du Bois HLA-DQB1*0201: A Marker for Good Prognosis in British and Dutch Patients with Sarcoidosis Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 406 - 412. [Abstract] [Full Text] [PDF]

				M. C. Iannuzzi, M. Maliarik, and B. A. Rybicki Nomination of a Candidate Susceptibility Gene in Sarcoidosis . The Complement Receptor 1 Gene Am. J. Respir. Cell Mol. Biol., July 1, 2002; 27(1): 3 - 7. [Full Text] [PDF]

				R. M. du Bois The Genetic Predisposition to Interstitial Lung Disease : Functional Relevance Chest, March 1, 2002; 121(2007): 14S - 20S. [Abstract] [Full Text] [PDF]